Publications

Heterogeneity in clone dynamics within and adjacent to intestinal tumours identified by Dre-mediated lineage tracing.

Authors: A-S Thorsen, D Khamis, R Kemp, M Colombé, FC Lourenço, E Morrissey, D Win...

E-pub date: 1 Jan 2020

Journal name: Dis Model Mech

Erratum for the Report: “Aging increases cell-to-cell transcriptional variability upon immune stimulation” by C. P. Martinez-Jimenez, N. Eling, H.-C. Chen, C. A. Vallejos, A. A. Kolodziejczyk, F. Connor, L. Stojic, T. F. Rayner, M. J. T. Stubbington, S. A. Teichmann, M. de la Roche, J. C. Marioni, D. T. Odom.

Authors:

E-pub date: 20 Dec 2019

Journal name: Science

B cells rapidly target antigen and surface-derived MHCII into peripheral degradative compartments.

Authors: S Hernández-Pérez, M Vainio, E Kuokkanen, V Šuštar, P Petrov, S Forsté...

E-pub date: 20 Dec 2019

Journal name: J Cell Sci

Grayscale-to-Color: Scalable Fabrication of Custom Multispectral Filter Arrays.

Authors: C Williams, GSD Gordon, TD Wilkinson, SE Bohndiek

E-pub date: 18 Dec 2019

Journal name: ACS Photonics

Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.

Authors: J Bornschein, L Wernisch, M Secrier, A Miremadi, J Perner, S MacRae, M O'Do...

E-pub date: 15 Dec 2019

Journal name: Int J Cancer

Characterising optical fibre transmission matrices using metasurface reflector stacks for lensless imaging without distal access

Authors: GSD Gordon, M Gataric, AGCP Ramos, R Mouthaan, C Williams, J Yoon, TD Wilki...

E-pub date: 9 Dec 2019

Journal name: Physical Review X

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.

Authors: AR Clamp, EC James, IA McNeish, A Dean, J-W Kim, DM O'Donnell, J Hook, C Co...

E-pub date: 7 Dec 2019

Journal name: Lancet

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.

Authors: NS Meagher, L Wang, PF Rambau, MP Intermaggio, DG Huntsman, LR Wilkens, MA ...

E-pub date: 1 Dec 2019

Journal name: Mod Pathol

Filters

Research Groups

Core Facilities

Start date

End date

Heterogeneity in clone dynamics within and adjacent to intestinal tumours identified by Dre-mediated lineage tracing.

B cells rapidly target antigen and surface-derived MHCII into peripheral degradative compartments.

Grayscale-to-Color: Scalable Fabrication of Custom Multispectral Filter Arrays.

Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.

Characterising optical fibre transmission matrices using metasurface reflector stacks for lensless imaging without distal access

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Heterogeneity in clone dynamics within and adjacent to intestinal tumours identified by Dre-mediated lineage tracing.

B cells rapidly target antigen and surface-derived MHCII into peripheral degradative compartments.

Grayscale-to-Color: Scalable Fabrication of Custom Multispectral Filter Arrays.

Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.

Characterising optical fibre transmission matrices using metasurface reflector stacks for lensless imaging without distal access

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.